Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

Twenty games into the season, Dalton Johnson hands out team grades for the Golden State Warriors after an average start to the 2025-26 NBA season.

It’s been a long trip but the newest suburban Brick & Mortar co-working space is open in a prime spot across from Cook Park in downtown Libertyville. Built as A&P Grocery store, the single-story ...

Vanguard Extended Market ETF VXF tracks a total market index that excludes S&P 500 stocks. It’s a misfit in the mid-cap blend category, but it pairs well with a fund that tracks the S&P 500 index to ...

WEST LAFAYETTE, Ind. — The U.S. Department of Agriculture has selected Indianapolis as one of five hub locations to relocate the agency’s staff and other resources from the Washington, D.C., area. The ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

Do you find yourself nagging your partner about things they simply don't seem to care about, while they do the same to you? The solution isn't trying to change each other. Instead, it's learning to ...

DelveInsight’s 'Complement Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline complement inhibitors in various stages of clinical development, major ...

Please provide your email address to receive an email when new articles are posted on . At the ASRS annual meeting, there were panel discussions about the pros and cons of these types of therapies, ...

Ever wonder about the inspiration behind Barbie, the most iconic of dolls? Or have you been curious about political muckraking and mudslinging in the days before TV and social media? Or maybe you have ...

Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics Commit Biologics is pioneering a novel approach ...